Lenalidomide offers effective treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Source: Inpharma, Volume 1, Number 1648, 2008-07-26 , pp. 17-17(1)

Publisher: Adis International

Keywords: Lenalidomide, therapeutic use; Non-Hodgkin's-lymphoma, treatment

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/inp/2008/00000001/00001648/art00055
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1648&spage=17&epage=17